Some of the patients wonder why others are going through surgery before chemotherapy, while others are going through chemotherapy before surgery. Which one is good?
The order of treatment and surgery for breast cancer patients is as follows:
Early patients who have surgical conditions are generally treated first;
Early patients who have relatively large tumours and wish to be breast-protected may first undergo new assisted chemotherapy, and then breast-protected treatment after the swelling and reduction of the disease;
3. Partially late-stage patients do not meet the signs of the operation, which should be followed by chemotherapy;
The first stage IV patient is treated in a whole-of-body manner, taking into account the method of intervention when circumstances permit.
Breast cancer is a common treatment strategy known as new assisted chemotherapy. Newly assisted chemotherapy has significant advantages in some cases.
1. Inclination of tumours: Newly assisted chemotherapy can reduce tumours before surgery, making tumours that are otherwise difficult to remove easier to remove. This is particularly important for patients with larger tumours or whose position is detrimental to surgery.
2. Increased possibility of breast-pulse surgery: by first taking chemotherapy, the size of tumours can be reduced, thereby increasing the chances of choosing breast-pulse surgery and avoiding full mammography.
3. Assessing the effectiveness of treatment: Newly assisted chemotherapy can provide early treatment response information, and if tumours are sensitive to chemotherapy, such treatment programmes can continue; if not, doctors can adjust treatment strategies in a timely manner.
4. Control of micro-transfer stoves: Newly assisted chemotherapy helps to control potential micro-transfer stoves at an early stage and reduces the risk of re-emergence at a distance.
5. Improvements: Some studies have shown that new assisted chemotherapy increases the survival and non-sick life expectancy of some patients, especially for triple and Her2 positive breast cancer.
Although there are many advantages to new assisted chemotherapy, it does not apply to all breast cancer patients. Specific treatment programmes are determined by a comprehensive assessment of the patient ‘ s condition, the type of tumor and individual differences.
